Wei Huang, Ph.D., conducts research on oncologic magnetic resonance imaging, using advanced MR techniques for early and accurate cancer detection and monitoring therapeutic response. His focus is to improve breast cancer diagnostic accuracy and reduce unnecessary biopsy procedures on women with benign lesions. Dr. Huang's research uses the Shutter-Speed Model dynamic contrast-enhanced (DCE) MRI technique that was developed at the Advanced Imaging Research Center. He also uses multiple functional MR methods—vessel size index MRI, DCE-MRI, diffusion-weighted MRI, and proton MR spectroscopy—for early prediction of breast cancer response to chemotherapy and for accurate assessment of residual cancer after therapy for optimum surgical planning/decision. Other ongoing or planned oncologic MR research studies cover the topics of soft tissue sarcoma, head & neck cancer, liver cancer, and colon-rectal cancer.

Dr. Huang obtained his bachelor's degree in 1988 from Fudan University, Shanghai, China and his Ph.D. in physical chemistry in 1994 from State University of New York, Stony Brook.  He was a postdoctoral fellow at the National Institutes of Health from 1995 to 1998. Dr. Huang has more than eighteen years of experience in in vivo MR research.  He joined the OHSU Advanced Imaging Research Center in 1998.